Jeffrey W. Albers
2017
In 2017, Jeffrey W. Albers earned a total compensation of $4.9M as President and Chief Executive Officer at Blueprint Medicines, a 128% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $325,975 |
|---|---|
| Option Awards | $4,088,976 |
| Salary | $515,375 |
| Other | $8,100 |
| Total | $4,938,426 |
Albers received $4.1M in option awards, accounting for 83% of the total pay in 2017.
Albers also received $326K in non-equity incentive plan, $515.4K in salary and $8.1K in other compensation.
Rankings
In 2017, Jeffrey W. Albers' compensation ranked 1,916th out of 14,666 executives tracked by ExecPay. In other words, Albers earned more than 86.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,916 out of 14,666 | 87th |
Division Manufacturing | 647 out of 5,772 | 89th |
Major group Chemicals And Allied Products | 171 out of 2,075 | 92nd |
Industry group Drugs | 126 out of 1,731 | 93rd |
Industry Pharmaceutical Preparations | 96 out of 1,333 | 93rd |
Source: SEC filing on April 27, 2018.
Albers' colleagues
We found six more compensation records of executives who worked with Jeffrey W. Albers at Blueprint Medicines in 2017.
2017
Christopher Murray
Blueprint Medicines
Senior Vice President, Technical Operations
2017
Anthony Boral
Blueprint Medicines
Chief Medical Officer
2017
Kathryn Haviland
Blueprint Medicines
Chief Operating Officer
2017
Kate Haviland
Blueprint Medicines
Chief Business Officer
2017
Michael Landsittel
Blueprint Medicines
Vice President, Finance
2017
Tracey McCain
Blueprint Medicines